221 related articles for article (PubMed ID: 21400501)
21. Identification of diagnostic markers in colorectal cancer via integrative epigenomics and genomics data.
Kok-Sin T; Mokhtar NM; Ali Hassan NZ; Sagap I; Mohamed Rose I; Harun R; Jamal R
Oncol Rep; 2015 Jul; 34(1):22-32. PubMed ID: 25997610
[TBL] [Abstract][Full Text] [Related]
22. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer.
Goel A; Nagasaka T; Arnold CN; Inoue T; Hamilton C; Niedzwiecki D; Compton C; Mayer RJ; Goldberg R; Bertagnolli MM; Boland CR
Gastroenterology; 2007 Jan; 132(1):127-38. PubMed ID: 17087942
[TBL] [Abstract][Full Text] [Related]
23. Gene promoter and exon DNA methylation changes in colon cancer development - mRNA expression and tumor mutation alterations.
Molnár B; Galamb O; Péterfia B; Wichmann B; Csabai I; Bodor A; Kalmár A; Szigeti KA; Barták BK; Nagy ZB; Valcz G; Patai ÁV; Igaz P; Tulassay Z
BMC Cancer; 2018 Jun; 18(1):695. PubMed ID: 29945573
[TBL] [Abstract][Full Text] [Related]
24. Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas.
Zhang X; Song YF; Lu HN; Wang DP; Zhang XS; Huang SL; Sun BL; Huang ZG
World J Gastroenterol; 2015 Mar; 21(9):2629-37. PubMed ID: 25759530
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive DNA Methylation Analysis Reveals a Common Ten-Gene Methylation Signature in Colorectal Adenomas and Carcinomas.
Patai ÁV; Valcz G; Hollósi P; Kalmár A; Péterfia B; Patai Á; Wichmann B; Spisák S; Barták BK; Leiszter K; Tóth K; Sipos F; Kovalszky I; Péter Z; Miheller P; Tulassay Z; Molnár B
PLoS One; 2015; 10(8):e0133836. PubMed ID: 26291085
[TBL] [Abstract][Full Text] [Related]
26. DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT.
Bosch LJ; Oort FA; Neerincx M; Khalid-de Bakker CA; Terhaar sive Droste JS; Melotte V; Jonkers DM; Masclee AA; Mongera S; Grooteclaes M; Louwagie J; van Criekinge W; Coupé VM; Mulder CJ; van Engeland M; Carvalho B; Meijer GA
Cancer Prev Res (Phila); 2012 Mar; 5(3):464-72. PubMed ID: 22135045
[TBL] [Abstract][Full Text] [Related]
27. Use of DNA from human stools to detect aberrant CpG island methylation of genes implicated in colorectal cancer.
Belshaw NJ; Elliott GO; Williams EA; Bradburn DM; Mills SJ; Mathers JC; Johnson IT
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1495-501. PubMed ID: 15342451
[TBL] [Abstract][Full Text] [Related]
28. Non-CpG island promoter hypomethylation and miR-149 regulate the expression of SRPX2 in colorectal cancer.
Øster B; Linnet L; Christensen LL; Thorsen K; Ongen H; Dermitzakis ET; Sandoval J; Moran S; Esteller M; Hansen TF; Lamy P; ; Laurberg S; Ørntoft TF; Andersen CL
Int J Cancer; 2013 May; 132(10):2303-15. PubMed ID: 23115050
[TBL] [Abstract][Full Text] [Related]
29. Identifying CpG sites with different differential methylation frequencies in colorectal cancer tissues based on individualized differential methylation analysis.
Yan H; He J; Guan Q; Cai H; Zhang L; Zheng W; Qi L; Zhang S; Liu H; Li H; Zhao W; Yang S; Guo Z
Oncotarget; 2017 Jul; 8(29):47356-47364. PubMed ID: 28537885
[TBL] [Abstract][Full Text] [Related]
30. Aberrant CpG island hypermethylation of multiple genes in colorectal neoplasia.
Lee S; Hwang KS; Lee HJ; Kim JS; Kang GH
Lab Invest; 2004 Jul; 84(7):884-93. PubMed ID: 15122305
[TBL] [Abstract][Full Text] [Related]
31. GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer.
Hellebrekers DM; Lentjes MH; van den Bosch SM; Melotte V; Wouters KA; Daenen KL; Smits KM; Akiyama Y; Yuasa Y; Sanduleanu S; Khalid-de Bakker CA; Jonkers D; Weijenberg MP; Louwagie J; van Criekinge W; Carvalho B; Meijer GA; Baylin SB; Herman JG; de Bruïne AP; van Engeland M
Clin Cancer Res; 2009 Jun; 15(12):3990-7. PubMed ID: 19509152
[TBL] [Abstract][Full Text] [Related]
32. ADAMTS1, CRABP1, and NR3C1 identified as epigenetically deregulated genes in colorectal tumorigenesis.
Lind GE; Kleivi K; Meling GI; Teixeira MR; Thiis-Evensen E; Rognum TO; Lothe RA
Cell Oncol; 2006; 28(5-6):259-72. PubMed ID: 17167179
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic inactivation of the candidate tumor suppressor USP44 is a frequent and early event in colorectal neoplasia.
Sloane MA; Wong JW; Perera D; Nunez AC; Pimanda JE; Hawkins NJ; Sieber OM; Bourke MJ; Hesson LB; Ward RL
Epigenetics; 2014 Aug; 9(8):1092-100. PubMed ID: 24837038
[TBL] [Abstract][Full Text] [Related]
34. Promoter region methylation does not account for the frequent loss of expression of the Fas gene in colorectal carcinoma.
Butler LM; Dobrovic A; Bianco T; Cowled PA
Br J Cancer; 2000 Jan; 82(1):131-5. PubMed ID: 10638979
[TBL] [Abstract][Full Text] [Related]
35. Walking pathways with positive feedback loops reveal DNA methylation biomarkers of colorectal cancer.
Kel A; Boyarskikh U; Stegmaier P; Leskov LS; Sokolov AV; Yevshin I; Mandrik N; Stelmashenko D; Koschmann J; Kel-Margoulis O; Krull M; Martínez-Cardús A; Moran S; Esteller M; Kolpakov F; Filipenko M; Wingender E
BMC Bioinformatics; 2019 Apr; 20(Suppl 4):119. PubMed ID: 30999858
[TBL] [Abstract][Full Text] [Related]
36. Toward a comprehensive and systematic methylome signature in colorectal cancers.
Ashktorab H; Rahi H; Wansley D; Varma S; Shokrani B; Lee E; Daremipouran M; Laiyemo A; Goel A; Carethers JM; Brim H
Epigenetics; 2013 Aug; 8(8):807-15. PubMed ID: 23975090
[TBL] [Abstract][Full Text] [Related]
37. Frequent CpG island methylation in serrated adenomas of the colorectum.
Park SJ; Rashid A; Lee JH; Kim SG; Hamilton SR; Wu TT
Am J Pathol; 2003 Mar; 162(3):815-22. PubMed ID: 12598316
[TBL] [Abstract][Full Text] [Related]
38. Methyl-CpG binding column-based identification of nine genes hypermethylated in colorectal cancer.
Kober P; Bujko M; Olędzki J; Tysarowski A; Siedlecki JA
Mol Carcinog; 2011 Nov; 50(11):846-56. PubMed ID: 21438024
[TBL] [Abstract][Full Text] [Related]
39. [A new quantitative DNA-methylation analysis of MSI colorectal cancers helps to separate sporadic colorectal cancers from HNPCC-candidates].
Bettstetter M; Rümmele P; Hofstädter F; Dietmaier W
Verh Dtsch Ges Pathol; 2006; 90():236-43. PubMed ID: 17867602
[TBL] [Abstract][Full Text] [Related]
40. Identification of GABRA1 and LAMA2 as new DNA methylation markers in colorectal cancer.
Lee S; Oh T; Chung H; Rha S; Kim C; Moon Y; Hoehn BD; Jeong D; Lee S; Kim N; Park C; Yoo M; An S
Int J Oncol; 2012 Mar; 40(3):889-98. PubMed ID: 22038115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
